Edesa Biotech Inc (EDSA)

Edesa Biotech Inc (EDSA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $36.1M; returns 1 day +0.4%, 1 week +7.8%, 1 year +3.0%.

Edesa Biotech Inc. (EDSA) is a clinical-stage biopharmaceutical company based in Canada, primarily focused on the research, development, and commercialization of innovative treatments for inflammatory and immune-related diseases.

Groups EDSA belongs to

• Biotechnology
• Canada Companies
• Biopharmaceutical
• Clinical Stage
• Clinical Stage Biopharma
• Healthcare
• Monoclonal Antibodies
• Autoimmune Diseases
• Dermatology
• Canada
• Pharmaceuticals
• Life Sciences

EDSA financial model: income statement, cash flow and balance sheet